share_log

Citigroup Initiates Coverage On Voyager Therapeutics With Buy Rating, Announces Price Target of $12

Citigroup Initiates Coverage On Voyager Therapeutics With Buy Rating, Announces Price Target of $12

花旗集团开始对voyager therapeutics进行覆盖,给予买入评级,并宣布目标价格为12美元
Benzinga ·  2024/12/02 06:41  · 评级/大行评级

Citigroup analyst Samantha Semenkow initiates coverage on Voyager Therapeutics (NASDAQ:VYGR) with a Buy rating and announces Price Target of $12.

花旗集团分析师萨曼莎·塞门科开始对voyager therapeutics(纳斯达克:VYGR)进行覆盖,给予买入评级,并宣布目标价为12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发